Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

100
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870 article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically Dr. Robert Califf Commissioner US Food and Drug Administration Silver Spri
ng, MD 20993 Dear Dr. Califf,
Jul 31, 2023
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006 article
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006
Submitted electronically Joni Rutter, Ph.D. National Center for Advancing Translational Sciences Na
tional Institutes of Health 6701 Democracy Blvd Bethesda, MD 20892-4874 Dear Director Rutter,
May 12, 2023
Statement on the Zero-Draft Resolution of the “Scope, modalities, format and organization of the High Level Meeting on Antimicrobial Resistance convened by the President of the General Assembly” article
Statement on the Zero-Draft Resolution of the “Scope, modalities, format and organization of the High Level Meeting on Antimicrobial Resistance convened by the President of the General Assembly”
Submitted electronically 
Jan 18, 2024
TRAIN Newsletter — July 2024 article
TRAIN Newsletter — July 2024
TRAIN eNews is delivered directly to organizations that take part in The Research Acceleration and I
nnovation Network (TRAIN).
Jul 25, 2024
Request for Information on Improving Americans’ Access to Gene Therapies article
Request for Information on Improving Americans’ Access to Gene Therapies
Submitted electronically The Honorable Bill Cassidy, M.D. Ranking Member Committee on Health, Educa
tion, Labor & Pensions United States Senate Washington, DC 20510 Dear Ranking Member Cassidy,
Jan 22, 2024
An Update from MI Health—July 2024 article
An Update from MI Health—July 2024
In This Issue:
Jul 17, 2024
Medicare Drug Price Negotiation Program comment letter article
Medicare Drug Price Negotiation Program comment letter
Submitted electronically Dr. Meena Seshamani Deputy Administrator and Director, Center for Medicare
Centers for Medicare & Medicaid Services US Department of Health and Human Services Baltimore, MD 21244
Apr 14, 2023
Center for Public Health Newsletter: Summer 2022 article
Center for Public Health Newsletter: Summer 2022
Executive Director’s Note, It’s been a busy few months since our inaugural newsletter!
Jul 12, 2022
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
Jul 1, 2024
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners video
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners
How can patient organizations hoping to leverage the resources of industry researchers attract the
ir support and establish formal industry partnerships?
Apr 3, 2024
Request for Information on Next-Generation Cures Bill article
Request for Information on Next-Generation Cures Bill
The Honorable Diana DeGette US House of Representatives Washington, DC 20515
Aug 1, 2024
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package article
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package
The Milken Institute applauds Congress on the passage of the FY2023 Omnibus Appropriations bill.
Dec 23, 2022